XM does not provide services to residents of the United States of America.
3
3

3iGroup

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Top of the Street: H&M, L'Oreal, EQT, Rheinmetall, Eni, ASMI

BUZZ-Top of the Street: H&M, L'Oreal, EQT, Rheinmetall, Eni, ASMI A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank double-upgrades H&M HMb.ST to "buy" from "sell", saying it expects structural earnings growth to be higher than the growth potential recognised by the market ** RBC raises L'Oreal OREP.PA to "sector perform" from "underperform", saying the French cosmetics giant has maintained volume growth despite significant price increases an
3
A
E
J
L
N
R
V
H

UK's 3i down after Morgan Stanley cuts to "equal weight"

BUZZ-UK's 3i down after Morgan Stanley cuts to "equal weight" ** Shares of the British multinational private equity and venture capital firm 3i Group III.L down ~1.25% at 3009p ** Morgan Stanley downgrades co to "equal-weight" from "overweight", as it awaits capital market recovery ** Brokerage says, compounding characteristics of 3i-owned discount
3

ASMI, EasyJet, Kooth

EUROPE RESEARCH ROUNDUP-ASMI, EasyJet, Kooth July 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ASMI, EasyJet and Kooth, on Wednesday. HIGHLIGHTS * ASMI ASMI.AS : Jefferies raises target price to EUR 880 from EUR 780 * B.P. Marsh & Partners Plc BPM.L : Jefferies raises target price to 625p from 560p * EasyJet EZJ.L : JP Morgan cuts target price to 640p from 670p * Kooth Plc KOO.L : Berenberg initiates coverage with buy rating;
3
A
A
A
A
B
B
C
C
C
D
D
E
E
E
F
K
A
H
A
A
D

Adyen, AstraZeneca, Auto Trader

EUROPE RESEARCH ROUNDUP-Adyen, AstraZeneca, Auto Trader July 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen, AstraZeneca and Auto Trader, on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : Jefferies cuts target price to EUR 1,695 from EUR 1,821 * AstraZeneca AZN.L : Jefferies raises target price to 11,700p from 11,300p * Auto Trader AUTOA.L : Jefferies raises target price to 935p from 830p * Halma HLMA.L : HSBC raises target pri
3
A
A
A
B
C
C
C
E
E
E
G
H
R
S
S
V
A
A
A
A
A
B
N
N
S

Admiral, Maersk, Raspberry PI

EUROPE RESEARCH ROUNDUP-Admiral, Maersk, Raspberry PI June 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral, Maersk and Raspberry, on Tuesday. HIGHLIGHTS * Admiral ADML.L : Berenberg raises to buy from hold; raises PT to 3,127p from 2,973p * Direct Line Insurance DLGD.L : Berenberg cuts to hold from buy * IMI Plc IMI.L : JP Morgan raises target price to 2,200p from 1,850p * Maersk MAERSKb.CO : Morgan Stanley raises target
3
A
A
B
B
C
E
G
H
H
I
K
K
K
L
M
M
N
O
S
S
W
D
R

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.